LivingGLP1
Study S000271

6-Months Exenatide and Glucose Homeostasis Determinants in Type 2 Diabetic Patients

ClinicalTrials.gov record

Registration

Registration
NCT00948168
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
COMPLETED
Enrollment
34
Start
2008-07
Primary completion
2009-07
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:exenatide (Byetta)
Results posted
FALSE

Registered primary outcomes

  • Improvement in HbA1c [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.